Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Tuberculosis
•
Pulmonology
•
Pulmonary Infections
How do you approach a positive IGRA in a patient with idiopathic NSIP needing a prolonged course of corticosteroid therapy and a prior history MAC in a single sputum culture?
Related Questions
What is the interpretation of an IGRA with positive TB wells and negative nil and negative mitogen wells?
What is the interpretation of two IGRAs with negative mitogen wells, in the absence of immunosuppression?
Are there situations where you would consider treating E faecalis or E faecium that grows from a respiratory culture?
How would you treat an asymptomatic patient with a positive Blastomyces antibody, evidence of prior granulomatous lung disease on imaging, and who may require immunosuppression in the future?
How do you manage a 3 cm solitary pulmonary cryptococcoma in an asymptomatic, immunocompetent, HIV-negative host?
Is there a specific criteria that you use to determine if a patient with respiratory symptoms should have a multiplex respiratory test performed?
Do you prolong IV therapy or reduce the number of antibiotic agents for patients with pulmonary NTM infections who have completed induction IV therapy and cannot access oral antibiotic therapy due to cost?
Would you start treatment for MAC in a patient with nodular bronchiectatic disease who has demonstrated radiographic progression but remains asymptomatic and smear-negative?
Have you incorporated the use of MycoTOX profiles into your clinical practice and, if so, in what capacity?
Do you prescribe empiric antibiotics to patients with CAP who test positive for a respiratory virus?
